8-K - TScan Therapeutics, Inc. (0001783328) (Filer)
Published . Updated .
Filed: 2026-10-16 AccNo: 0001193125-26-424198 Size: 138 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Directly affected
- TCRX TScan Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-16 AccNo: 0001193125-26-424198 Size: 138 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Source: sec-edgar
Price since this story was published: TScan Therapeutics (TCRX)
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.98% | still updating |
| GLD | three days earlier | -1.59% | final price |
| GLD | five days earlier | +0.03% | final price |
| QQQ | that day | +1.20% | final price |
| QQQ | the next day | +0.87% | still updating |
| QQQ | three days earlier | +2.70% | final price |
| QQQ | five days earlier | +5.10% | final price |
| SPY | that day | +0.43% | final price |
| SPY | the next day | +0.61% | still updating |
| SPY | three days earlier | +0.83% | final price |
| SPY | five days earlier | +1.93% | final price |
| TScan Therapeutics (TCRX) | that day | -9.00% | final price |
| TScan Therapeutics (TCRX) | three days earlier | -10.67% | final price |
| TScan Therapeutics (TCRX) | five days earlier | +1.67% | final price |
| TLT | that day | -0.72% | final price |
| TLT | the next day | +0.10% | still updating |
| TLT | three days earlier | -1.44% | final price |
| TLT | five days earlier | -2.51% | final price |
Who gains and who loses around TScan Therapeutics (TCRX)
Companies tied to this story
- TCRX TScan Therapeutics
In “8-K - TScan Therapeutics, Inc. (0001783328) (Filer),” TScan Therapeutics (TCRX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TCRX
How “8-K - TScan Therapeutics, Inc. (0001783328) (Filer)” reaches TScan Therapeutics (TCRX)
TScan Therapeutics (TCRX) is the company in “8-K - TScan Therapeutics, Inc. (0001783328) (Filer),” the 16 Oct 2026 this story story.
What ties TScan Therapeutics (TCRX) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> TCRX
Dates in the story, and the TScan Therapeutics (TCRX) price range
TCRX traded between 0.21 and 0.24 across 2 sessions. The latest close on file is 0.21.
How strong the case is around TScan Therapeutics (TCRX)
44 out of 100Price not final
“8-K - TScan Therapeutics, Inc. (0001783328) (Filer)” scores 44 out of 100. The score uses 1 sources, a -9.43% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.